AOD-9604 vs. 5-Amino-1MQ

Head-to-head comparison based on the profiles in the PepCycle library.

AttributeAOD-96045-Amino-1MQ
ClassMetabolic PeptidesMetabolic
DescriptionA modified fragment of human growth hormone (HGH 177-191) researched for fat metabolism without affecting blood sugar or growth. WOAHA small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that boosts cellular NAD+ levels by blocking the enzyme responsible for NAD+ degradation. Promotes fat metabolism, increases energy expenditure, and supports metabolic health — often called a "fat loss peptide" though technically a small molecule.
Dose in studies250-500 mcg per day(Only Researched in Mice) 50-150 mg/day oral (capsule). Typical: 100 mg/day. Users Report 2.5 - 5 mg daily for Humanresearch
FrequencyDaily, split into 1-2 dosesOnce daily or split into 2 doses (morning + midday)
Half-life~30 minutesOral bioavailability: good | Plasma half-life: ~4-6 hours
Cycle length8-12 weeks on, 4 weeks off8-12 weeks on, 4 weeks off. Can be used in cycles or continuously at maintenance dose.
Research level3/5 – Moderate research1/5 – Very limited research

AOD-9604: full profile · 5-Amino-1MQ: full profile

Values from research literature – not medical advice.